---
schema_version: "secwatch.filing_event.v1"
accession: "0001398733-25-000030"
form_type: "8-K"
ticker: "AQST"
cik: "0001398733"
company_name: "Aquestive Therapeutics, Inc."
filed_at: "2025-11-06T23:59:59+00:00"
generated_at: "2026-05-16T23:34:41.212975+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Aquestive Therapeutics files Q3 2025 investor presentation; no specific financial details disclosed in filing text

## Summary
- Form 8-K filed on November 6, 2025, under Item 7.01 for Regulation FD disclosure.
- Investor presentation attached as Exhibit 99.1, titled 'Q3 Earnings Supplemental Materials'.
- Presentation available on company's website, but full content not included in provided filing text.

## SEC filing metadata
- accession: 0001398733-25-000030
- form_type: 8-K
- ticker: AQST
- cik: 0001398733
- company_name: Aquestive Therapeutics, Inc.
- filed_at: 2025-11-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/0001398733-25-000030-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1398733/000139873325000030/aqst-20251106.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001398733-25-000030
- JSON: https://secwatch.observer/filing/0001398733-25-000030.json
- Plain text: https://secwatch.observer/filing/0001398733-25-000030.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.